Profile
ACRV VRTX REGN SGEN ALNY ARGX
Company Name Acrivon Therapeutics, Inc. Common Stock Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $58.00M $130.72B $58.75B $43.15B $35.25B $34.28B
Employees 0.08K 6.10K 15.11K 3.26K 2.23K 1.60K
CEO Dr. Peter Blume-Jensen M.D., Ph.D. Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Dr. Yvonne L. Greenstreet M.B.A., M.D. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
ACRV VRTX REGN SGEN ALNY ARGX
Quant Rating Score 2 2 4 3 1 3
Quant Rating Sell Sell Buy Neutral Strong Sell Neutral
Trading
ACRV VRTX REGN SGEN ALNY ARGX
Last Close $1.85 $485.89 $549.28 $228.74 $230.5 $587.59
High 52 $10.54 $516.74 $1201.76 $228.74 $296.75 $671.75
Low 52 $1.36 $392.81 $546.39 $228.74 $143.31 $356.01
Price vs. 52 Week High -82.45 % -5.97 % -54.29 % 0 % -22.33 % -12.53 %
Price vs. 52 Week Low 36.03 % 23.7 % 0.53 % 0 % 60.84 % 65.05 %
Total Return
ACRV VRTX REGN SGEN ALNY ARGX
1 Month Return -66.36 % -5.42 % -18.95 % 0 % -8.97 % -4.33 %
3 Month Return -67.99 % 15.14 % -19.41 % 0 % -6.4 % -8.26 %
6 Month Return -76.46 % -2.58 % -44.96 % 0 % -22.31 % 8.15 %
9 Month Return -75.94 % -0.51 % -49.4 % 0 % -3.97 % 26.8 %
YTD Return -69.27 % 20.66 % -22.89 % 0 % -2.04 % -4.46 %
1 Year Return -82.11 % 23.6 % -39.05 % 0 % 58.62 % 60.46 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACRV VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.16 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -23.72 % -1.65 % 5.37 % -2.27 % -0.24 % -44.32 %
Dividend Per Share (TTM) - - 0.88 % - - -
Payout Ratio (TTM) - - - - - -
Growth
ACRV VRTX REGN SGEN ALNY ARGX
Asset Growth 42.18 % -0.87 % 14.15 % -1.21 % 10.71 %
Gross Profit Growth 100 % 10.25 % 8.23 % 22.93 % 26.81 %
Revenue Growth - 11.66 % 8.27 % 24.65 % 22.97 %
Revenue 3 Year - 45.6 % -13.44 % 91.56 % 145.29 %
Revenue 5 Year - 163.93 % 82.78 % 215.48 % 769.33 %
Revenue 10 Year - 1632.15 % 429.43 % 494.04 % 2468.51 %
EBIT Growth -32.66 % -105.41 % -1.39 % 10.13 % 37.31 %
Net Income Growth -33.4 % -114.8 % 11.61 % 9.51 % 36.82 %
Net Income 3 Yeari Growth Per Share 69.39 % -122.89 % -46.47 % -763.59 % 69.96 %
Net Income 5 Yeari Growth Per Share 6.28 % -145.38 % 111.07 % -276.93 % 73.33 %
Net Income 10 Yeari Growth Per Share 6.28 % 33.84 % 1232.49 % -624.16 % 55.42 %
Operating Income Growth -32.66 % -105.41 % -1.39 % 10.13 % 37.31 %
Operating Cash Flow Growth (CFG) -54 % -113.93 % -3.78 % 9.07 % -107.98 %
Operating 3 Year CFG 71.01 % -118.65 % -38.85 % -147.99 % 98.81 %
Operating 5 Year CFG -44.62 % -131.3 % 84.11 % -195.86 % 97.46 %
Operating 10 Year CFG -44.62 % 12.43 % 517.51 % -2622.09 % 97.1 %
EPS Growth 91.24 % -114.8 % 10.39 % 10.81 % 38.64 %
EPS Diluted Growth 91.24 % -114.97 % 10.27 % 10.81 % 38.64 %
Book Value Per Share -90.47 % -6.59 % 11.76 % -9.83 % 129.53 %
Share Holder 3 Year Equity Growth Per Share 145.84 % 62.6 % 53.21 % 33.72 % -89.49 %
Share Holder 5 Year Equity Growth Per Share 229.72 % 168.85 % 167.88 % 220.81 % -96.04 %
Share Holder 10 Year Equity Growth Per Share 229.72 % 1265.7 % 1113.59 % 691.19 % -95.86 %
Dividend Per Share Growth - - - - -
Dividend 3 Year Growth Per Share - - - - -
Dividend 5 Year Growth Per Share - - - - -
Dividend 10 Year Growth Per Share - - - - -
Debt Growth -21.51 % 116.42 % 0.06 % -23.28 % -51.69 %
Free Cash Flow Growth -55.79 % -124.1 % -0.08 % 3.67 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2022 31 Dec 2024
Profitability
ACRV VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM - 86.09 % 84.47 % 72.37 % 85.62 % 46.33 %
Return on Assets TTM -40.98 % -2.38 % 11.69 % -11.76 % -6.56 % 13.45 %
Return on Equity TTM -46.18 % -3.28 % 14.77 % -16.53 % 905.33 % 16.83 %
Return on Capital Employed TTM -49.73 % -1.3 % 10.89 % -16.87 % -5.79 % -0.31 %
Net Income Per EBT TTM 100 % -215.53 % 92.32 % 100.55 % 73.71 % 25990.14 %
EBT Per Ebit TTM 90.31 % -100.69 % 118.85 % 94.01 % 213.34 % -18.79 %
EBIT Per Revenue TTM - -2.24 % 28.32 % -36.09 % -7.87 % -0.77 %
Cash Flow To Debt Ratio TTM -1801.62 % -28.16 % 222.76 % -185.98 % -0.64 % -201.37 %
Receivables Turnover TTM - 6.84 2.29 1.98 5.55 2.46
Payables Turnover TTM 0.56 3.71 2.79 1.54 3.66 1.83
Inventory Turnover TTM - 1.27 0.71 0.65 4.12 2.93
Fixed Asset Turnover TTM - 425.82 % 308.76 % 256.83 % 323.99 % 5106.8 %
Asset Turnover TTM - 48.84 % 37.61 % 34.46 % 53.02 % 35.83 %
Operating Cash Flow Per Share TTM -0.35 -1.91 41.08 -1.12 -0.06 -1.07
Free Cash Flow Per Share TTM -0.36 -3.07 33.43 -1.62 -0.33 -1.09
Cash Per Share TTM 95.46 % 2375.11 % 16647.4 % 657.5 % 2095.42 % 4597.04 %
Operating Cash Flow Sales Ratio TTM - -4.48 % 31.13 % -16.85 % -0.37 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 104.22 % 160.43 % 81.38 % 144.14 % 512.38 % 102.26 %
Cash Flow Coverage Ratios TTM -1801.62 % -28.16 % 222.76 % -185.98 % -0.64 % -201.37 %
Price To Free Cash Flows Ratio TTM -0.85 -165.4 16.33 -141.85 -827.74 -444.85
Price To Operating Cash Flows Ratio TTM -5.3 -266.09 13.37 -203.89 -4192.79 -531.16
Price Cash Flow Ratio TTM -5.3 -266.09 13.37 -203.89 -4192.79 -531.16
Income Statement (TTM)
ACRV VRTX REGN SGEN ALNY ARGX
Revenue $0B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $0B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.09B $0.49B $5.32B $-0.62B $-0.18B $0B
Net Income $-0.08B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -0.24 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
ACRV VRTX REGN SGEN ALNY ARGX
Long Term Debt $0B $1.66B $2.7B $0.04B $0B $0.03B
Total Liabilities $0.02B $6.12B $8.41B $0.87B $4.17B $0.68B
Total Equity $0.18B $16.41B $29.35B $2.8B $0.07B $5.31B
Total Investments $0.14B $6.65B $6.52B $1.42B $1.73B $1.82B
Total Debt $0B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.2B $22.53B $37.76B $3.67B $4.24B $5.99B
Cash Flow Statement (TTM)
ACRV VRTX REGN SGEN ALNY ARGX
Net Income $-0.08B $-0.54B $4.41B $-0.61B $-0.28B $0.8B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.07B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0.03B $-0B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 19.005
ABCL AbCellera Biologics Inc. 2.425
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.83
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 0.9009
ABPWW 0.0465
ABSI Absci Corporation 3.095
ABUS Arbutus Biopharma Corporation 3.16
ABVC ABVC BioPharma, Inc. 0.8525
ABVX Abivax SA American Depositary Shares 6.44
ACAD ACADIA Pharmaceuticals Inc. 14.72
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.5229
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 1.99
ACIU AC Immune SA 1.48
ACLX Arcellx, Inc. 62.06
ETFs With Exposure to ACRV
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00104 186.58
VTI Vanguard Total Stock Market Index Fund 0 258.815
IBB iShares Biotechnology ETF 0.00568 118.32
SCHB Schwab U.S. Broad Market ETF 0.000454367 20.265
SCHA Schwab U.S. Small-Cap ETF 0.00262412 21.825
IWN iShares Russell 2000 Value ETF 0.00237 140.06
IWO iShares Russell 2000 Growth ETF 0.00305 240.61
BIB ProShares Ultra Nasdaq Biotechnology 0.0057516 41.32
VXF Vanguard Extended Market Index Fund 0 161.92
HDG ProShares Hedge Replication ETF 0.000337538 47.64
UWM ProShares Ultra Russell2000 0.000892061 28.56
VTHR Vanguard Russell 3000 Index Fund 0 232.17
IWC iShares Micro-Cap ETF 0.00742 104.29
URTY ProShares UltraPro Russell2000 0.000514702 26.43
VTWV Vanguard Russell 2000 Value Index Fund 0 123.55
VTWO Vanguard Russell 2000 Index Fund 0 75.38
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 87.8
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 87.79
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 44.94
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 44.93
VBINX Vanguard Balanced Index Fund Investor Shares 0 44.94
RYLD Global X Russell 2000 Covered Call ETF 0 14.3
IBBQ Invesco Nasdaq Biotechnology ETF 0.005 19.8
DFAT Dimensional U.S. Targeted Value ETF 0.00004125 47.32
DFAS Dimensional U.S. Small Cap ETF 0.00007608 55.64
DFAC Dimensional U.S. Core Equity 2 ETF 0.00003739 30.88
VTSAX Vanguard Total Stock Market Index Fund 0 125.68
NTKI Nationwide Russell 2000 Risk-Managed Income ETF 0 19.0104
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.00497 5.7275
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 121.91
VITSX Vanguard Total Stock Market Index Fund 0 125.7
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.00497 5.711
DFSU Dimensional US Sustainability Core 1 ETF 0.00033937 33.645
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000104799 88.58
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 121.92
SWSSX Schwab Small-Cap Index Fund-Select Shares 0.00356256 29.97
AVSC Avantis U.S. Small Cap Equity ETF 0 44.68
VEMPX Vanguard Extended Market Index InstlPlus 0 300.86
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 235.79
RSSL Global X Funds 0 73.285
DXUV Dimensional ETF Trust 0.00002398 46.9899
RFLR Innovator ETFs Trust 0 23.42
Unlock